EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark HAEMATOKINE was filed as Word mark on 08/10/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/11/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018286902 |
| Application date | August 10, 2020 |
| Publication date | September 3, 2020 |
| Entry date | December 11, 2020 |
| Expiration date | August 10, 2030 |
Trademark owner
Joukahaisenkatu 6
20520 Turku
FI
20520 Turku
FI
Trademark representatives
Eteläinen Rautatiekatu 10 A
00100 Helsinki
FI
goods and services
1
Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; Biological preparations for use in industry and science; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Culture media for microbiology; Cell growth media for growing cells for scientific use; Cultures, other than for medical or veterinary use; Cultures of cell media [other than for medical or veterinary use]; Cultures of microorganisms, other than for medical and veterinary use; Blood culture media for scientific use; Biological preparations, other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for scientific purposes; Stem cells for research purposes
5
Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes; Stem cells; Stem cells for medical purposes; Tumor suppressing agents; Antineoplastics; Anti-neoplastic preparations of chemical origin; Anti-neoplastic preparations of microbial origin; Anti-cancer preparations; Compounds for treating cancer; Antibodies; Antibodies for medical use to treat inflammation and cancer growth and spread; Adjuvants for medical purposes; Vaccine adjuvants; Biological adjuvants for medical purposes; Anti-inflammatories; Antigens; Antitumor drugs; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use; Culture media for medical use; Media for bacteriological cultures; Cell growth media for growing cells for medical use; Biological preparations for medical purposes; Mixed biological preparations for medical purposes; Biological preparations for veterinary purposes; Immunomodulators; Immunostimulants; Injectable pharmaceuticals; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances with anti-inflammatory properties; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical products for the treatment of bone diseases; Regulatory proteins for medical use; Serotherapeutic medicines; Synthetic peptides for pharmaceutical purposes; Pharmaceutical products for treating respiratory diseases; Compounds for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases; Compounds for treating correlated pulmonary syndromes; Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; Pharmaceutical preparations for treatment and prevention of multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates
ID: 11018286902